Guided Therapeutics, Inc. Share Price
Stocks
GTHP
US40171F5017
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2800 USD | +14.29% |
|
+7.69% | -48.15% |
| 16/06 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| 15/05 | Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 2.7Cr 2.36Cr 2.17Cr 2.02Cr 3.84Cr 257.37Cr 3.9Cr 26Cr 10Cr 126.51Cr 10Cr 9.93Cr 435.94Cr | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 2.99Cr 2.61Cr 2.4Cr 2.24Cr 4.25Cr 284.75Cr 4.31Cr 29Cr 11Cr 139.97Cr 11Cr 11Cr 482.33Cr | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +14.29% | ||
| 1 week | +7.69% | ||
| Current month | +16.67% | ||
| 1 month | +22.81% | ||
| 3 months | +16.67% | ||
| 6 months | -48.15% | ||
| Current year | -48.15% |
| 1 week | 0.2 | 0.28 | |
| 1 month | 0.18 | 0.34 | |
| Current year | 0.17 | 0.54 | |
| 1 year | 0.12 | 0.54 | |
| 3 years | 0.06 | 0.54 | |
| 5 years | 0.06 | 0.78 | |
| 10 years | 0.02 | 5,760 |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/03 | Free | Director | 1,10,000 | 0.1316% | ||
| 10/03 | Others | Director | 10 | 0.9747% | ||
| 10/03 | Free | Chairman | 1,10,000 | 0.1316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +14.29% | +7.69% | +5.46% | +24.44% | 2.7Cr | ||
| +1.97% | +3.50% | +22.37% | +0.32% | 19TCr | ||
| +5.87% | +6.59% | -21.20% | +24.59% | 15TCr | ||
| +2.17% | +2.44% | -2.26% | -17.53% | 14TCr | ||
| +4.83% | +2.13% | -56.44% | -16.55% | 6.71TCr | ||
| +2.59% | +5.18% | +22.53% | +0.04% | 5.43TCr | ||
| +0.03% | +1.66% | -26.25% | -32.57% | 4.46TCr | ||
| -2.02% | -3.56% | +8.31% | +8.68% | 3.69TCr | ||
| +0.31% | +0.64% | +7.78% | +42.30% | 3.72TCr | ||
| +1.09% | +0.96% | -13.87% | -19.29% | 2.98TCr | ||
| Average | +2.52% | +2.73% | -5.36% | +1.44% | 7.56TCr | |
| Weighted average by Cap. | +1.52% | +3.35% | -3.59% | +0.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7T 6.12T 5.62T 5.24T 9.94T 7L 10.09T 67.51T 26.25T 3L 26.28T 25.71T 11.29L | 8L 7L 6L 6L 10.89L 7.3Cr 11.06L 73.98L 28.76L 3.59Cr 28.79L 28.17L 12Cr |
| Net income | -24.17L -21.13L -19.42L -18.1L -34.33L -23Cr -34.85L -2.33Cr -90.62L -11Cr -90.72L -88.78L -39Cr | -31.96L -27.94L -25.68L -23.93L -45.39L -30Cr -46.08L -3.08Cr -1.2Cr -15Cr -1.2Cr -1.17Cr -52Cr |
| Net Debt | 17.71L 15.48L 14.23L 13.26L 25.15L 17Cr 25.54L 1.71Cr 66.4L 8.29Cr 66.48L 65.05L 29Cr | 28.76L 25.14L 23.11L 21.54L 40.85L 27Cr 41.47L 2.77Cr 1.08Cr 13Cr 1.08Cr 1.06Cr 46Cr |
Employees
3
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/26/02 | $0.2800 | +14.29% | 5,570 |
| 01/26/01 | $0.2450 | +2.08% | 11,276 |
| 30/26/30 | $0.2400 | +19.94% | 200 |
| 29/26/29 | $0.2001 | -16.62% | 3,771 |
| 26/26/26 | $0.2400 | -7.69% | 106 |
- Stock Market
- Stocks
- GTHP Stock
Select your edition
All financial news and data tailored to specific country editions
















